Michael M. Allevato

781 total citations
15 papers, 336 citations indexed

About

Michael M. Allevato is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Michael M. Allevato has authored 15 papers receiving a total of 336 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 7 papers in Molecular Biology and 4 papers in Cancer Research. Recurrent topics in Michael M. Allevato's work include Cancer Immunotherapy and Biomarkers (5 papers), Peptidase Inhibition and Analysis (4 papers) and Lung Cancer Research Studies (3 papers). Michael M. Allevato is often cited by papers focused on Cancer Immunotherapy and Biomarkers (5 papers), Peptidase Inhibition and Analysis (4 papers) and Lung Cancer Research Studies (3 papers). Michael M. Allevato collaborates with scholars based in United States, Thailand and China. Michael M. Allevato's co-authors include J. Silvio Gutkind, Alfredo Molinolo, Zhiyong Wang, Ezra E.W. Cohen, Mara Gilardi, Victoria H. Wu, Yusuke Goto, Bryan S. Yung, Lynn Vitale‐Cross and Andrew B. Sharabi and has published in prestigious journals such as Nature Communications, Genes & Development and SHILAP Revista de lepidopterología.

In The Last Decade

Michael M. Allevato

13 papers receiving 334 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael M. Allevato United States	7	178	145	79	61	56	15	336
Rocío Granda‐Díaz Spain	12	182 1.0×	174 1.2×	66 0.8×	93 1.5×	48 0.9×	20	374
Frank Tsai United States	14	185 1.0×	278 1.9×	154 1.9×	58 1.0×	97 1.7×	36	483
Simona Nuzzo Italy	7	222 1.2×	214 1.5×	65 0.8×	84 1.4×	46 0.8×	10	388
Cera Nieto United States	9	198 1.1×	136 0.9×	69 0.9×	101 1.7×	89 1.6×	10	349
Marion Gilormini France	5	169 0.9×	138 1.0×	25 0.3×	93 1.5×	83 1.5×	7	329
Rachel A. Woolaver United States	9	144 0.8×	158 1.1×	132 1.7×	53 0.9×	40 0.7×	12	317
Yongchu Sun China	9	194 1.1×	99 0.7×	33 0.4×	135 2.2×	39 0.7×	14	313
Irati Garmendia Spain	8	112 0.6×	98 0.7×	42 0.5×	54 0.9×	44 0.8×	12	219
Hongjuan Xu China	9	233 1.3×	88 0.6×	61 0.8×	155 2.5×	68 1.2×	21	372
Jung Hwa Moon South Korea	8	267 1.5×	182 1.3×	35 0.4×	117 1.9×	26 0.5×	10	372

Countries citing papers authored by Michael M. Allevato

Since Specialization

Citations

This map shows the geographic impact of Michael M. Allevato's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael M. Allevato with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael M. Allevato more than expected).

Fields of papers citing papers by Michael M. Allevato

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael M. Allevato. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael M. Allevato. The network helps show where Michael M. Allevato may publish in the future.

Co-authorship network of co-authors of Michael M. Allevato

This figure shows the co-authorship network connecting the top 25 collaborators of Michael M. Allevato. A scholar is included among the top collaborators of Michael M. Allevato based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael M. Allevato. Michael M. Allevato is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Lesperance, Jacqueline, Bryan S. Yung, Michael M. Allevato, et al.. (2025). Interactions of Antibody Drug Conjugate Anti‐Tubulin and Topoisomerase I Inhibitor Payloads with Radiotherapy to Potentiate Immunotherapy. Advanced Science. e06552–e06552.

Wu, Xingyu, Keiichi Koshizuka, Kuniaki Sato, et al.. (2024). Oncogenic HRAS Induces Metformin Resistance in Head and Neck Cancer by Promoting Glycolytic Metabolism. Cancer Prevention Research. 17(12). 571–583. 2 indexed citations

Allevato, Michael M., Keiichi Koshizuka, Daniela Nachmanson, et al.. (2024). A genome-wide CRISPR screen reveals that antagonism of glutamine metabolism sensitizes head and neck squamous cell carcinoma to ferroptotic cell death. Cancer Letters. 598. 217089–217089. 8 indexed citations

Goto, Yusuke, Keiichi Koshizuka, Toshinori Ando, et al.. (2024). A Kinome-Wide Synthetic Lethal CRISPR/Cas9 Screen Reveals That mTOR Inhibition Prevents Adaptive Resistance to CDK4/CDK6 Blockade in HNSCC. Cancer Research Communications. 4(7). 1850–1862. 3 indexed citations

Lesperance, Jacqueline, Dina V. Hingorani, Michael M. Allevato, et al.. (2024). Tumor-Targeted Cell-Penetrating Peptides Reveal That Monomethyl Auristatin E Temporally Modulates the Tumor Immune Microenvironment. Molecules. 29(23). 5618–5618. 5 indexed citations

Forner, David, et al.. (2024). Patient‐Initiated Communication After Parotidectomy. The Laryngoscope. 135(3). 1105–1112.

Allevato, Michael M., et al.. (2024). Parotidectomy Trends Toward Outpatient for Benign Disease. Otolaryngology. 172(3). 905–912. 1 indexed citations

Allevato, Michael M., Marina Vorontchikhina, Wataru Ichikawa, et al.. (2023). MYC acetylated lysine residues drive oncogenic cell transformation and regulate select genetic programs for cell adhesion-independent growth and survival. Genes & Development. 37(19-20). 865–882. 10 indexed citations

Allevato, Michael M., Joshua D. Smith, Michael Brenner, & Steven B. Chinn. (2023). Tumor-Derived Exosomes and the Role of Liquid Biopsy in Human Papillomavirus Oropharyngeal Squamous Cell Carcinoma. The Cancer Journal. 29(4). 230–237. 4 indexed citations

10.

Hingorani, Dina V., Michael M. Allevato, Maria F. Camargo, et al.. (2022). Monomethyl auristatin antibody and peptide drug conjugates for trimodal cancer chemo-radio-immunotherapy. Nature Communications. 13(1). 3869–3869. 39 indexed citations

11.

Wang, Zhiyong, Yusuke Goto, Michael M. Allevato, et al.. (2021). Disruption of the HER3-PI3K-mTOR oncogenic signaling axis and PD-1 blockade as a multimodal precision immunotherapy in head and neck cancer. Nature Communications. 12(1). 2383–2383. 51 indexed citations

12.

Saddawi‐Konefka, Robert, Farhoud Faraji, Michael M. Allevato, et al.. (2021). 601 Sequencing immunotherapy before lymphatic ablation unleashes cDC1-dependent antitumor immunity in HNSCC. SHILAP Revista de lepidopterología. A631–A631. 2 indexed citations

13.

Wang, Zhiyong, Xiaodong Feng, Alfredo Molinolo, et al.. (2019). 4E-BP1 Is a Tumor Suppressor Protein Reactivated by mTOR Inhibition in Head and Neck Cancer. Cancer Research. 79(7). 1438–1450. 54 indexed citations

14.

Wang, Zhiyong, Victoria H. Wu, Michael M. Allevato, et al.. (2019). Syngeneic animal models of tobacco-associated oral cancer reveal the activity of in situ anti-CTLA-4. Nature Communications. 10(1). 5546–5546. 119 indexed citations

15.

Allevato, Michael M., Eugene Bolotin, Mark H. Grossman, et al.. (2017). Sequence-specific DNA binding by MYC/MAX to low-affinity non-E-box motifs. PLoS ONE. 12(7). e0180147–e0180147. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact